Published in November 2023, the scoping document highlights the changes which followed the NPCA’s move into the National Cancer Audit Collaborating Centre (NATCAN) and outlines the proposed future scope and design of NPCA which considers the needs of stakeholders whilst driving local and national quality improvement in services and outcomes for prostate cancer patients.
The NPCA aims to guide changes in practice so that they will save lives and improve quality of life, through supporting five key quality improvement goals which centre on:
• Maintaining use of active surveillance to treat men with low-risk prostate cancer, thus reducing potential over-treatment
• Increasing use of multimodality therapy for men with high-risk or locally advance prostate cancer, thus reducing potential under-treatment
• Improving safety and reducing toxicity of prostate cancer therapy
• Reducing variation in prostate cancer management among NHS providers
• Improving experience of care among men with prostate cancer